Another Day, Another Math Problem

While smaller companies aren't required to certify their financial results with the Securities and Exchange Commission Wednesday, recent disclosures from some of these firms suggest they are taking that edict and the new securities laws seriously.

Generic drugmaker Andrx(ADRX), for example, came clean Tuesday about accounting irregularities that took place over the last three years. During a conference call with analysts, the company said a low-level manager altered records pertaining to its accounts receivable, or money owed and not collected, by up to $15 million since January 1999.

Shares of Andrx fell $2.78, or 12%, to $20.54 Tuesday.

"Based on our discussions with the employee, he claimed that he did this on his own accord, not at the instruction of management, solely so his job performance could appear to be better than it was," said Chief Financial Officer Angelo Malahias on the conference call.

Analysts suggest the accounting misstep could have inflated earnings by as much as 4% since 1999.

Many Mistakes

Because Andrx had sales of less than $1.2 billion last year, its chief executive and chief financial officer aren't required to swear to the accuracy of past results. But the drugmaker said it would be in compliance with the Sarbanes-Oxley Act, which requires all publicly traded firms to certify future SEC filings.

Under the new law, officers who make false certifications will face penalties of $1 million and/or up to 10 years in prison if the violation was "knowing," and $5 million and/or up to 20 years imprisonment if the violation was "willful."

"Some of these smaller companies are still within the SEC radar screen," said Thomas Hazen, a securities law professor at the University of North Carolina. "They may not be subject to certification, but the Sarbanes-Oxley legislation is going to cover all companies."

Cutter & Buck (CBUK) -- another company that won't be signing a sworn affidavit Wednesday -- said it, too, uncovered accounting irregularities in fiscal 2000 and 2001 and that its chief financial officer has resigned.

The sportswear company said it would restate results to correct entries of sales into incorrect periods, and inaccurate reporting of sales by distribution channels. Shares of Cutter & Black fell 58 cents, or 14%, to $3.44.

Several other companies have also adjusted their numbers recently, including Hanover Compressor (HC), MSC Industrial Direct (MSM), Bio-Technology General (BTGC) and A&P (GAP), although the latter actually revised its earnings higher for 2001 and 1999.

"We seem to be in a new regime," said Edward Ketz, an accounting professor at Penn State's Smeal College of Business. "The markets have hit everyone hard, and these companies feel that they can't be penalized that much more, especially if it's a fairly minor indiscretion. This might be a good time to clean house."

Meeting Deadlines

In all, almost 950 companies ultimately will have to confirm the accuracy of their financials. At this point, around 400 companies that have Wednesday as a deadline still haven't certified their past results. About 200 companies will have longer to certify -- in some cases up to Nov. 29 -- because their fiscal years don't end Dec. 31.

The SEC has said it will post the results on its Web site, although delays are expected, and some results might not be known until next week.

One company that must certify Wednesday is Symbol Technologies (SBL), a maker of bar code and scanning technology. The company said Tuesday that the SEC is investigating the timing and amount of revenue it recognized from January 2000 to December 2001.

Reliant Resources (RRI) and Aon Corp. (AOC), which have also warned about earnings restatements over the past few months, are among the companies required to certify results on Wednesday.

>To order reprints of this article, click here: Reprints